Fenofibrate or Silymarin for Early Sepsis Treatment
Treatments studied
Part of Infections clinical trials.
This study tests whether two medications—fenofibrate (used for cholesterol) or silymarin (a plant extract)—can help treat sepsis (a serious blood infection) when given early. Researchers want to see if either drug reduces complications and improves survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with sepsis (blood infection from any cause)
- You do not have severe organ failure or shock at the time of enrollment
- You have not had a serious stomach or intestinal disease
- You do not have advanced liver or kidney disease
- You are not pregnant, breastfeeding, or allergic to fenofibrate or silymarin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether a drug called fisetin can slow the progression of sepsis once you are admitted to the hospital. It may help patients recover more quickly or avoid worsening, but eligibility depends on how severe the illness is and what other treatments you need.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
This trial looks at a new program to improve how doctors and nurses treat sepsis (a severe infection that can cause organ failure) in the emergency department. It aims to see if the program helps start the right treatments faster.
This study uses heart ultrasound (echocardiography) to help doctors decide how much fluid to give patients with sepsis, a serious blood infection. The goal is to improve how well the heart pumps and help patients recover better.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.